These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14715828)

  • 1. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.
    Maffei L; Murata Y; Rochira V; Tubert G; Aranda C; Vazquez M; Clyne CD; Davis S; Simpson ER; Carani C
    J Clin Endocrinol Metab; 2004 Jan; 89(1):61-70. PubMed ID: 14715828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome.
    Maffei L; Rochira V; Zirilli L; Antunez P; Aranda C; Fabre B; Simone ML; Pignatti E; Simpson ER; Houssami S; Clyne CD; Carani C
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):218-24. PubMed ID: 17547681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.
    Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V
    Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.
    Morishima A; Grumbach MM; Simpson ER; Fisher C; Qin K
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3689-98. PubMed ID: 8530621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters.
    Rochira V; Faustini-Fustini M; Balestrieri A; Carani C
    J Clin Endocrinol Metab; 2000 May; 85(5):1841-5. PubMed ID: 10843162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroids and sexual desire in a man with a novel mutation of aromatase gene and hypogonadism.
    Carani C; Granata AR; Rochira V; Caffagni G; Aranda C; Antunez P; Maffei LE
    Psychoneuroendocrinology; 2005 Jun; 30(5):413-7. PubMed ID: 15721053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
    Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
    Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy.
    Deladoëy J; Flück C; Bex M; Yoshimura N; Harada N; Mullis PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4050-4. PubMed ID: 10566648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase.
    Li X; Nokkala E; Yan W; Streng T; Saarinen N; Wärri A; Huhtaniemi I; Santti R; Mäkelä S; Poutanen M
    Endocrinology; 2001 Jun; 142(6):2435-42. PubMed ID: 11356692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene.
    Herrmann BL; Saller B; Janssen OE; Gocke P; Bockisch A; Sperling H; Mann K; Broecker M
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5476-84. PubMed ID: 12466340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
    Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
    Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin, estrogen replacement therapy and gonadotropin inhibition fail to improve insulin sensitivity in a girl with aromatase deficiency.
    Guercio G; Di Palma MI; Pepe C; Saraco NI; Prieto M; Saure C; Mazza C; Rivarola MA; Belgorosky A
    Horm Res; 2009; 72(6):370-6. PubMed ID: 19844126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.
    Verma N; Jain V; Birla S; Jain R; Sharma A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.
    Chen Z; Wang O; Nie M; Elison K; Zhou D; Li M; Jiang Y; Xia W; Meng X; Chen S; Xing X
    Mol Cell Endocrinol; 2015 Jan; 399():32-42. PubMed ID: 25301327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tall stature without growth hormone: four male patients with aromatase deficiency.
    Rochira V; Zirilli L; Maffei L; Premrou V; Aranda C; Baldi M; Ghigo E; Aimaretti G; Carani C; Lanfranco F
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1626-33. PubMed ID: 20164294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals.
    Bunck MC; Toorians AW; Lips P; Gooren LJ
    Eur J Endocrinol; 2006 Apr; 154(4):569-75. PubMed ID: 16556720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency.
    Herrmann BL; Janssen OE; Hahn S; Broecker-Preuss M; Mann K
    Horm Metab Res; 2005 Mar; 37(3):178-83. PubMed ID: 15824973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.
    Agarwal VR; Takayama K; Van Wyk JJ; Sasano H; Simpson ER; Bulun SE
    J Clin Endocrinol Metab; 1998 May; 83(5):1797-800. PubMed ID: 9589695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase deficiency in men: a clinical perspective.
    Rochira V; Carani C
    Nat Rev Endocrinol; 2009 Oct; 5(10):559-68. PubMed ID: 19707181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.